Skip to content
GLP-1 Savers
Menu
Ranked #350 · Watch List

SkyRx review

SkyRx sells compounded semaglutide as either an injection or oral drops from $199 a month on a twelve-month prepaid plan, dispensed through FDA-registered 503B pharmacies, with tirzepatide still listed as coming soon.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

From $199/mo (all doses, 12-month plan, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The $199 needs twelve months paid up front, which SkyRx's own footnote says and its headline does not. Two other things worth knowing before you compare it: tirzepatide is listed as coming soon rather than available, and SkyRx states plainly that GLP-1s are not yet offered in all 50 states without naming which.

How much does SkyRx cost?

The price SkyRx publishes is From $199/mo (all doses, 12-month plan, compounded). We flag this one to watch: confirm the ongoing rate with SkyRx before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $199/mo (all doses, 12-month plan, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

SkyRx scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait80/100
Nationwide Availability45/100
Both Molecules62/100
Easy Cancellation25/100
Reputation65/100

Why it's a deal

  • Dispenses through US-based 503B compounding pharmacies registered with the FDA — the more heavily regulated of the two routes, and stated explicitly
  • Maintains LegitScript certification
  • Oral drops are priced the same as the injection at $199, so the needle-free route carries no premium
  • Says outright that GLP-1s are not available in every state rather than implying nationwide coverage

Read the fine print

  • The $199 rate requires a twelve-month subscription paid up front — there is no month-to-month figure published beside it
  • Tirzepatide is listed as coming soon in both injection and oral form, so semaglutide is the only real choice today
  • The states it does serve are never enumerated, so eligibility is unknown until you apply
  • Compounded only — no FDA-approved brand-name route

The bottom line

Best for: Someone committed to semaglutide for a year who wants a 503B pharmacy behind it. SkyRx sells compounded semaglutide as either an injection or oral drops from $199 a month on a twelve-month prepaid plan, dispensed through FDA-registered 503B pharmacies, with tirzepatide still listed as coming soon.

Ranked #350 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to SkyRx, out of 426 others we track.

Shopping SkyRx against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs SkyRx, and every program that undercuts or outscores it — starting with Nurx, the closest match on score — is ranked on the SkyRx alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from SkyRx's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on SkyRx's site. Not medical advice; see our disclosure.

Where SkyRx ranks

See every program ranked by price →

← Back to all deals